Kelly received a B.S. from the University of Wisconsin-Madison, a Ph.D. from the University of Washington, and postdoctoral training here at LMRT. Her work bridges several facets of regenerative medicine, including pluripotent stem cell biology, transplantation, tissue engineering, and micro/nanofabrication. For more, see www.kellystevensscience.com
Shengyong is currently pursuing a PhD degree in the Biological Engineering Department at MIT under a fellowship from A*STAR, Singapore. He is interested in developing three-dimensional models of infectious diseases that affect the liver and liver regeneration.
Currently, Meghan is doing research with miniature in vitro liver models, using them for high-throughput screens with applications in compound safety testing, hepatic tissue engineering and liver regeneration.
Justin graduated from MIT in 2008 with a B.S. in Biological Engineering and a B.S. in Music. His undergraduate research in the lab of Bevin Engelward focused on the development of a partially-automated high-throughput assay for DNA damage to be used in toxicology screens and to study DNA repair kinetics. He is presently an MD-PhD student at Harvard Medical School and MIT. During his first year in medical school, he was involved in the design, manufacture, and testing of cellular and acellular lung assist devices in the lab of Joseph P. Vacanti.
At LMRT, Justin is interested in designing new nanoparticle-based strategies for enhancing drug and diagnostic delivery, including work interfacing with synthetic biology to create nanoparticles which modify their behavior and payload in a tumor context-dependent manner.
Andrew Warren is from Orlando, FL and received his B.S. from Johns Hopkins University in 2011. While at Hopkins, he investigated cartilage tissue engineering with Prof. Jennifer Elisseeff and studied Biomedical Engineering with a second major in Applied Mathematics and Statistics. He is currently pursuing a Ph.D. in Medical Engineering and Medical Physics (MEMP) in the Harvard-MIT Division of Health Sciences and Technology with funding from the National Science Foundation’s Graduate Research Fellowship Program.
In lab, Andrew engineers modular nanoparticle sensors that enable urinary detection of diseases including cancer, clotting disorders, and liver fibrosis. By designing different formulations of these nanoparticles, Andrew is interested in enabling safe, low-cost disease sensing that can sensitively and specifically detect difficult to diagnose diseases that lack endogenous biomarkers.
Outside of lab, he is broadly interested in global health, particularly in engineering new approaches for disease prevention, diagnosis, and treatment in low-resource environments. Towards this end, he led the development of a low-cost urinary point-of-care diagnostic for cancer and thrombotic disease using the nanoparticle disease sensors from his thesis work. Andrew has also worked, with funding from the Bill & Melinda Gates Foundation, to develop unmanned aerial vehicles (UAVs) that can be deployed to swiftly deliver vaccines over the last mile in rural environments to improve cost, quality, and coverage of vaccine supplies. In his spare time, he (in order of decreasing skill) enjoys running, biking, and swimming.Email: email@example.com
Vyas Ramanan grew up in Cerritos, CA, and dealt with his inability to make life decisions by attending a dual degree Management & Technology (M&T) program at the University of Pennsylvania. At Penn, he conducted research in membrane biophysics and in polymeric drug delivery, in which his thesis on light-responsive electrospun polymer mats resulted in 1 paper and 3 shocks from a 25 kilovolt power supply. Vyas rounded out his college experience by singing parodies on stage in a gecko suit and interning at a venture capital firm, where he made up for his own cash-poor studenthood by trying to learn instead how to make use of other peoples’ money. He is currently a graduate student in Medical Engineering and Medical Physics (MEMP) in the Harvard-MIT Health Sciences and Technology (HST) program within MIT’s Institute for Medical Engineering and Science (IMES), combining his affinity for acronyms with a keen interest in improving human health. His work in LMRT, as a Hertz Foundation and NSF fellow, spans tissue engineering, innate immunity and liver-specific viruses, and using genetic tools to develop therapeutics, from which he hopes one day he will have a coherent thesis. Vyas’ additional work, as part of a team using drones to improve vaccine delivery in the developing world, does not involve actually vaccinating patients from a drone... yet.
Colin came to MIT in 2013 after working as a research assistant in Sohail Tavazoie’s lab at the Rockefeller University in NYC, where he studied biomolecular and post-transcriptional mechanisms underlying cancer metastasis, particularly in melanoma. Before that, he graduated with a B.S. in Chemical Engineering from Cornell University in 2011.
At MIT, Colin is pursuing a Ph.D. in Medical Engineering & Medical Physics through the Harvard-MIT Health Sciences & Technology Program (HST). At LMRT, he is studying targeted, modular siRNA delivery vehicles for therapeutic applications in cancer and brain injury. Additionally, he is interested in research at the interface between nanotechnology and synthetic biology, to develop responsive, tunable cancer therapeutics.E-mail: firstname.lastname@example.org
Ben graduated from Humboldt State University in 2011 with a B.S. in Biology with a cellular/ molecular emphasis and a minor in chemistry. For the next year he received training in human stem cell biology and techniques while an intern in the California Institute for Regenerative Medicine (CIRM) Scholar program at University of California Davis (UC Davis). From 2012 to 2014 he continued to work at UC Davis under Dr. Mark Zern and Dr. Yuyou Duan. This work encompassed the derivation of hepatocytes from multiple human stem cells sources and repopulation trials in a variety of liver disease models.Email: email@example.com
Alex is currently pursuing an M.D./Ph.D. from Harvard Medical School in the Division of Health Sciences & Technology (HST) and the Biophysics Program at Harvard University. His research at the Koch Institute and LMRT focuses on engineering and applying nanotechnologies to impact the clinical management of cancer. Working with doctors at Massachusetts General Hospital, he is currently investigating the application of novel nanotherapeutic protocols in models of ovarian cancer and sarcoma. Alex is funded through the NIH Medical Scientist Training Program.
Alice is currently pursuing a doctoral degree in the Division of Health Sciences & Technology at MIT and the School of Engineering and Applied Sciences at Harvard University. She is interested in the application of novel biomaterials and nanotechnologies to tissue engineering, and her research focuses on the development and assessment of 3D implantable, hepatic tissues. She is supported by NSF and NDSEG graduate research fellowships.